1. Home
  2. VIR vs CCO Comparison

VIR vs CCO Comparison

Compare VIR & CCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • CCO
  • Stock Information
  • Founded
  • VIR 2016
  • CCO 1995
  • Country
  • VIR United States
  • CCO United States
  • Employees
  • VIR N/A
  • CCO N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • CCO Advertising
  • Sector
  • VIR Health Care
  • CCO Consumer Discretionary
  • Exchange
  • VIR Nasdaq
  • CCO Nasdaq
  • Market Cap
  • VIR 706.4M
  • CCO 616.3M
  • IPO Year
  • VIR 2019
  • CCO 2005
  • Fundamental
  • Price
  • VIR $5.08
  • CCO $1.32
  • Analyst Decision
  • VIR Strong Buy
  • CCO Hold
  • Analyst Count
  • VIR 10
  • CCO 6
  • Target Price
  • VIR $26.80
  • CCO $1.75
  • AVG Volume (30 Days)
  • VIR 1.5M
  • CCO 3.2M
  • Earning Date
  • VIR 10-30-2025
  • CCO 10-30-2025
  • Dividend Yield
  • VIR N/A
  • CCO N/A
  • EPS Growth
  • VIR N/A
  • CCO N/A
  • EPS
  • VIR N/A
  • CCO 0.04
  • Revenue
  • VIR $19,000,000.00
  • CCO $1,538,895,000.00
  • Revenue This Year
  • VIR N/A
  • CCO $6.16
  • Revenue Next Year
  • VIR $9.65
  • CCO $3.19
  • P/E Ratio
  • VIR N/A
  • CCO $30.24
  • Revenue Growth
  • VIR N/A
  • CCO 31.61
  • 52 Week Low
  • VIR $4.16
  • CCO $0.81
  • 52 Week High
  • VIR $14.45
  • CCO $1.77
  • Technical
  • Relative Strength Index (RSI)
  • VIR 51.83
  • CCO 57.90
  • Support Level
  • VIR $5.04
  • CCO $1.24
  • Resistance Level
  • VIR $5.39
  • CCO $1.43
  • Average True Range (ATR)
  • VIR 0.34
  • CCO 0.06
  • MACD
  • VIR 0.05
  • CCO 0.00
  • Stochastic Oscillator
  • VIR 49.20
  • CCO 45.24

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

Share on Social Networks: